Works matching IS 15747891 AND DT 2018 AND VI 12 AND IP 3
Results: 10
Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 406, doi. 10.1002/1878-0261.12174
- By:
- Publication type:
- Article
MAD2L2 inhibits colorectal cancer growth by promoting NCOA3 ubiquitination and degradation.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 391, doi. 10.1002/1878-0261.12173
- By:
- Publication type:
- Article
AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 373, doi. 10.1002/1878-0261.12171
- By:
- Publication type:
- Article
Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 356, doi. 10.1002/1878-0261.12169
- By:
- Publication type:
- Article
A novel enediyne‐integrated antibody–drug conjugate shows promising antitumor efficacy against CD30<sup>+</sup> lymphomas.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 339, doi. 10.1002/1878-0261.12166
- By:
- Publication type:
- Article
Crosstalk between hepatitis B virus X and high‐mobility group box 1 facilitates autophagy in hepatocytes.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 322, doi. 10.1002/1878-0261.12165
- By:
- Publication type:
- Article
TGF‐β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 305, doi. 10.1002/1878-0261.12162
- By:
- Publication type:
- Article
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 287, doi. 10.1002/1878-0261.12148
- By:
- Publication type:
- Article
Inhibition of IL‐6‐JAK/Stat3 signaling in castration‐resistant prostate cancer cells enhances the NK cell‐mediated cytotoxicity via alteration of PD‐L1/NKG2D ligand levels.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 269, doi. 10.1002/1878-0261.12135
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 3, p. 267, doi. 10.1002/1878-0261.12122
- Publication type:
- Article